SenesTech, Inc.
SNES Nasdaq Agricultural Chemicals Financials FY2016βFY2025
What SenesTech, Inc. does
No business description yet.
- Legal name
- SenesTech, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 13, 2026
- Accession Β· CIK
- 0001628280-26-017384
0001680378
Revenue and margins
SenesTech, Inc. had $2.2M of revenue in fiscal 2025, up 19.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$5.9M in fiscal 2025, β265.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
SenesTech, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 369.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably SenesTech, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.3M | $4.8M | $5.4M | $1.3M | $8.6M |
| Debt incl. finance leases | $0.1M | $0.0M | β | β | β |
| Debt / equity | 0.0x | 0.0x | β | β | β |
| Interest coverage | β812.2x | β4,837.0x | β1,933.0x | β284.0x | β295.7x |
| Current ratio | 9.6x | 4.6x | 8.5x | 5.0x | 12.6x |
| Quick ratio | 8.7x | 4.0x | 7.5x | 3.6x | 11.4x |
| Total assets | $11.5M | $6.8M | $7.3M | $3.3M | $12.8M |
| Total liabilities | $1.5M | $1.5M | $0.9M | $0.8M | $3.3M |
| Shareholders' equity | $10.0M | $5.3M | $6.4M | $2.5M | $9.6M |
| Net debt (β = net cash) | β$9.3M | β$4.8M | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 9 | 4 / 9 | 3 / 9 | 4 / 9 | 7 / 9 | 5 / 9 | 4 / 8 | 3 / 8 | 4 / 8 |
| Accruals ratio | β31.8% | β26.7% | β32.5% | β30.8% | β23.0% | β5.6% | β12.2% | β2.0% | β2.9% | β7.9% |
| Altman Z'' | β10.13 | β25.51 | β37.12 | β72.95 | β58.99 | β24.49 | β60.00 | β52.82 | β140.22 | β31.77 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $0.3M | $0.1M | $0.3M | $0.1M | $0.3M | $0.6M | $1.0M | $1.2M | $1.9M | $2.2M |
| Gross profit | $0.3M | $0.0M | $0.1M | $0.0M | $0.0M | $0.2M | $0.5M | $0.5M | $1.0M | $1.4M |
| Research and development | $2.7M | $3.2M | $2.4M | $1.9M | $1.5M | $2.0M | $1.9M | $1.2M | $1.7M | $1.7M |
| Operating income | β$10.5M | β$12.3M | β$11.9M | β$10.3M | β$7.9M | β$8.9M | β$9.7M | β$7.7M | β$6.2M | β$6.5M |
| Interest expense | $0.0M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Income tax | β | β | β | β | β | β | β | β | $0.0M | $0.0M |
| Net income | β$10.8M | β$12.3M | β$11.9M | β$10.0M | β$8.4M | β$8.3M | β$9.7M | β$7.7M | β$6.2M | β$6.4M |
| Net income to common | β$11.0M | β$12.3M | β$12.2M | β$10.0M | β$8.4M | β | β | β | β | β |
| Diluted EPS | β$1.71 | β$1.12 | β$12.62 | β$7.69 | β$2.78 | β$14.77 | β$148.08 | β$115.10 | β$8.86 | β$1.95 |
| Diluted shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$6.7M | β$9.3M | β$9.1M | β$8.1M | β$7.1M | β$7.8M | β$8.6M | β$7.6M | β$6.0M | β$5.8M |
| Capital expenditure | $0.1M | $0.9M | $0.2M | $0.1M | $0.1M | $0.1M | $0.2M | $0.1M | $0.1M | $0.1M |
| Free cash flow | β$6.8M | β$10.2M | β$9.4M | β$8.1M | β$7.2M | β$7.9M | β$8.8M | β$7.7M | β$6.1M | β$5.9M |
| Depreciation and amortization | $0.2M | $0.4M | $0.4M | $0.4M | $0.3M | $0.3M | $0.2M | $0.1M | $0.2M | $0.1M |
| Stock-based compensation | $3.4M | $3.7M | $3.4M | $0.9M | $0.6M | $0.8M | $0.7M | $0.6M | $0.3M | $0.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $11.8M | $2.1M | $4.9M | $1.9M | $3.6M | $9.3M | $4.8M | $5.4M | $1.3M | $8.6M |
| Total debt | $0.2M | $0.8M | $0.7M | $0.4M | $0.9M | $0.1M | $0.0M | β | β | β |
| Finance lease liabilities | β | β | β | $0.1M | β | β | β | β | β | β |
| Current assets | $12.2M | $7.9M | $6.7M | $3.5M | $4.8M | $10.6M | $6.1M | $6.7M | $2.8M | $10.1M |
| Current liabilities | $1.8M | $1.2M | $1.2M | $1.6M | $0.8M | $1.1M | $1.3M | $0.8M | $0.6M | $0.8M |
| Inventory | $0.1M | $0.5M | $1.3M | $1.2M | $0.9M | $1.0M | $0.9M | $0.8M | $0.8M | $1.0M |
| Property and equipment, net | $0.6M | $1.5M | $1.1M | $0.7M | $0.5M | $0.3M | $0.3M | $0.4M | $0.4M | $0.4M |
| Total assets | $12.9M | $9.3M | $7.8M | $5.0M | $6.0M | $11.5M | $6.8M | $7.3M | $3.3M | $12.8M |
| Total liabilities | $2.0M | $1.8M | $1.4M | $2.4M | $2.1M | $1.5M | $1.5M | $0.9M | $0.8M | $3.3M |
| Preferred stock | β | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $10.8M | $7.5M | $6.3M | $2.6M | $3.9M | $10.0M | $5.3M | $6.4M | $2.5M | $9.6M |
| Margins | ||||||||||
| Gross margin | 100.0% | 13.5% | 18.9% | 29.4% | 0.4% | 40.7% | 45.5% | 45.2% | 54.1% | 62.5% |
| Operating margin | β3,306.9% | β23,684.6% | β4,000.0% | β7,193.7% | β2,813.1% | β1,489.0% | β949.4% | β648.1% | β336.5% | β292.9% |
| EBITDA margin | β3,245.3% | β22,932.7% | β3,849.5% | β6,904.9% | β2,711.0% | β1,438.5% | β931.4% | β636.8% | β328.1% | β286.8% |
| Net margin | β3,394.7% | β23,626.9% | β4,009.4% | β7,005.6% | β2,969.1% | β1,378.0% | β951.4% | β646.3% | β333.0% | β287.4% |
| FCF margin | β2,123.6% | β19,651.9% | β3,154.2% | β5,684.6% | β2,561.0% | β1,313.2% | β858.8% | β646.7% | β329.4% | β265.1% |
| Returns | ||||||||||
| Return on capital | β | β157.2% | β448.4% | β801.5% | β564.6% | β913.0% | β1,516.4% | β | β | β |
| Return on capital employed | β95.0% | β151.0% | β180.2% | β302.7% | β151.7% | β86.0% | β177.2% | β118.8% | β230.0% | β54.0% |
| Return on equity | β99.7% | β133.9% | β172.1% | β225.6% | β259.6% | β118.8% | β126.6% | β132.6% | β139.6% | β105.7% |
| Return on assets | β83.9% | β110.7% | β139.5% | β157.4% | β152.2% | β94.4% | β106.1% | β109.6% | β117.0% | β79.2% |
| Return on tangible equity | β101.2% | β163.3% | β193.9% | β390.7% | β215.6% | β82.4% | β183.7% | β121.4% | β246.3% | β66.7% |
| Growth | ||||||||||
| Revenue growth | β | β83.6% | 471.2% | β51.9% | 97.2% | 112.8% | 69.8% | 17.1% | 55.7% | 19.6% |
| Share count change | β | 70.2% | β91.1% | 34.4% | 130.6% | β81.4% | β88.3% | 2.3% | 941.8% | 369.3% |
| Financial health | ||||||||||
| Debt / equity | 0.0x | 0.1x | 0.1x | 0.1x | 0.2x | 0.0x | 0.0x | β | β | β |
| Interest coverage | β328.6x | β144.9x | β160.5x | β244.9x | β283.3x | β812.2x | β4,837.0x | β1,933.0x | β284.0x | β295.7x |
| Current ratio | 6.8x | 6.7x | 5.7x | 2.2x | 6.1x | 9.6x | 4.6x | 8.5x | 5.0x | 12.6x |
| Quick ratio | 6.8x | 6.3x | 4.7x | 1.5x | 4.9x | 8.7x | 4.0x | 7.5x | 3.6x | 11.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 17.9% | 1,726.9% | 80.5% | 49.7% | 40.4% | 16.7% | 17.1% | 12.5% | 4.5% | 6.2% |
| Stock comp / revenue | 1,058.8% | 7,169.2% | 1,149.2% | 610.5% | 228.7% | 127.5% | 69.8% | 46.5% | 17.6% | 11.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 1.0 | 4.0 | 3.0 | 4.0 | 7.0 | 5.0 | 4.0 | 3.0 | 4.0 |
| Altman Z'' | β10.1 | β25.5 | β37.1 | β73.0 | β59.0 | β24.5 | β60.0 | β52.8 | β140.2 | β31.8 |
| Accruals ratio | β31.8% | β26.7% | β32.5% | β30.8% | β23.0% | β5.6% | β12.2% | β2.0% | β2.9% | β7.9% |
Source: SEC EDGAR XBRL filings (CIK 0001680378). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.